Ethyl (2R)-2-methylbutanoate
Common Name: |
Ethyl (2R)-2-methylbutanoate |
IUPAC Name: |
ethyl (2R)-2-methylbutanoate |
Molecular Formula: |
C5H10OS |
SMILES: |
CCC(C)C(=O)OCC |
Inchi: |
1S/C7H14O2/c1-4-6(3)7(8)9-5-2/h6H,4-5H2,1-3H3/t6-/m1/s1 |
Inchi Key: |
HCRBXQFHJMCTLF-ZCFIWIBFSA-N |
Cas No: |
10307-61-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
118.20 |
Mass (g/mol) |
130.099 |
Molar Refractivity |
33.05 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
|
TPSA |
48.03 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
135.00 to 136.00 |
Vapor Pressure (mmHg@25.00 °C) |
7.853 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
1.596 |
iLOGP |
1.78 |
XLOGP3 |
1.00 |
WLOGP |
1.09 |
MLOGP |
0.76 |
ESOL Log S |
-1.20 |
ESOL Solubility (mg/ml) |
7.41 |
ESOL Solubility (mol/l) |
0.063 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.60 |
Ali Solubility (mg/ml) |
2.99 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.71 |
Silicos-IT Solubility (mg/ml) |
22.8 |
Silicos-IT Solubility (mol/l) |
0.19 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.31 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.589 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.339 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |